NCT03222011

Brief Summary

Two thirds of patients with Crohn's disease require intestinal surgery at some time in their life. Intestinal strictures, that is narrowing of the bowel due to inflammation and scarring, are the most common reason for surgery. Despite the high frequency, associated disability, and cost there are no are no treatment strategies that aim to improve the outcome of this disease complication. The STRIDENT (stricture definition and treatment) studies aim to develop such strategies.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 6, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 19, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

October 9, 2017

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2021

Completed
Last Updated

October 23, 2020

Status Verified

October 1, 2020

Enrollment Period

3.3 years

First QC Date

July 6, 2017

Last Update Submit

October 22, 2020

Conditions

Keywords

Crohn DiseaseInflammatory Bowel DiseaseIntestinal stricture

Outcome Measures

Primary Outcomes (1)

  • Improvement in obstructive symptoms using the Obstructive Symptom Score (OSS).

    The Obstructive Symptom Score (OSS) is a composite measure of the total number of days of obstructive abdominal pain and the severity over a fourteen-day period using a 5-point Likert scale. (no pain, mild, moderate, severe, unbearable)

    6 months

Secondary Outcomes (7)

  • Improvement in obstructive symptoms using the Obstructive Symptom Score (OSS).

    3, 6 and 12 months

  • Improvement in imaging parameters

    6 months

  • Improvement in endoscopic features

    6 months

  • Avoidance of surgery

    6 months

  • Improvement in patient reported outcomes (PROs)

    6 months

  • +2 more secondary outcomes

Study Arms (2)

Standard endoscopic therapy

ACTIVE COMPARATOR

Single endoscopic dilatation

Procedure: Standard (single) endoscopic stricture dilatation

Intensive endoscopic therapy

EXPERIMENTAL

3 endoscopic dilatations 3 weeks apart and possible needle knife strictureplasty

Procedure: Intensive endoscopic stricture dilatation

Interventions

single endoscopic stricture dilatation

Standard endoscopic therapy

3 endoscopic dilatations 3 weeks apart and possible needle knife strictureplasty

Intensive endoscopic therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Inflammatory bowel disease patients with intestinal stricture(s) identified on CT, MRI or endoscopy.

You may not qualify if:

  • Acute bowel obstruction requiring urgent surgical intervention
  • Deemed by treating physician to have high risk of acute bowel obstruction
  • Concurrent active perianal sepsis
  • Internal fistulising disease in association with strictures (entero-enteric stulas)
  • Low rectal or anal strictures
  • Evidence of dysplasia or malignancy from stricture biopsies or adjacent mucosal biopsies
  • Patients for whom endoscopy is not suitable due to co-morbidities or clinical state
  • Inability to give informed consent
  • Suspected perforation of the gastrointestinal tract
  • Pregnancy
  • Inability to undergo MRI small bowel due to a contraindication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Vincent's Hospital Melbourne

Melbourne, Victoria, 3065, Australia

RECRUITING

Related Publications (1)

  • Schulberg JD, Hamilton AL, Wright EK, Holt BA, Sutherland TR, Ross AL, Vogrin S, Kamm MA. Repeated endoscopic dilation and needle-knife stricturotomy for Crohn's disease strictures. Gastrointest Endosc. 2025 Jan;101(1):202-206.e4. doi: 10.1016/j.gie.2024.09.031. Epub 2024 Sep 27.

MeSH Terms

Conditions

Crohn DiseaseInflammatory Bowel DiseasesConstriction, Pathologic

Interventions

Single Person

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Marital StatusFamily CharacteristicsDemographyPopulation CharacteristicsSocioeconomic Factors

Study Officials

  • Emily Wright, MBBS PhD

    St Vincent's Hospital Melbourne

    PRINCIPAL INVESTIGATOR
  • Bronte Holt, MBBS PhD

    St Vincent's Hospital Melbourne

    PRINCIPAL INVESTIGATOR
  • Michael Kamm, MBBS PhD

    St Vincent's Hospital Melbourne

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Julien Schulberg, MBBS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Open label study
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomised controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Gastroenterology

Study Record Dates

First Submitted

July 6, 2017

First Posted

July 19, 2017

Study Start

October 9, 2017

Primary Completion

February 1, 2021

Study Completion

February 1, 2021

Last Updated

October 23, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations